Black Rock Inc. Innate Pharma Sa Transaction History

Black Rock Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.0 - $3.2 $29,260 - $46,816	-14,630 Reduced 2.94%	482,645 $965,000
Q2 2022 Aug 12, 2022	SELL	$2.0 - $3.55 $14,266 - $25,322	-7,133 Reduced 1.41%	497,275 $1.34 Million
Q1 2022 May 12, 2022	BUY	$2.7 - $4.8 $292,504 - $520,008	108,335 Added 27.35%	504,408 $1.7 Million
Q4 2021 Feb 10, 2022	BUY	$4.34 - $6.06 $1.72 Million - $2.4 Million	396,073 New	396,073 $1.81 Million

238K

Ticker IPHA
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,893,000
Market Cap $122M
Description
Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.